1Sniderman AD, Scantlebury T, Cianflone K. Hypertriglyceridemic hyperapoB: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus. Ann Intern Med, 2001,135: 447-459. 被引量：1
2Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res, 2002,43:1363-1379. 被引量：1
3Lemieux Ⅰ, Pascot A, Couillard C, et al. Hypertriglyceridem1ic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation, 2000, 102:179-184. 被引量：1
4Hussain MM, Obunike JC, Shaheen A, et al. High affinity binding between lipoprotein lipase and lipoproteins involves multiple ionic and hydrophobic interactions, does not require enzyme activity, and is modulated by glycosaminoglycans. J Biol Chem,2000,275:29324-29330. 被引量：1
5Artwohl M, Graier WF, Roden M,et al. Diabetic LDL triggers apoptosis in vascular endothelial cells. Diabetes,2003,52: 1240-1247. 被引量：1
6Zimmermann R, Panzenbock U, Wintersperger A, et al. Lipoprotein lipase mediates the uptake of glycated LDL in fibroblasts, endothelial cells, and macrophages. Diabetes,2001,50:1643-1653. 被引量：1
7Kern TS, Tang J, Mizutani M, et al. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci, 2000,41: 3972-3978. 被引量：1
8Chiang TM, Cole F, Woo-Rasberry V, et al. Role of nitric oxide in collagen-platelet interaction: involvement of platelet nonintegrin collagen receptor nitrotyrosylation. Thromb Res,2001, 102:343-352. 被引量：1
9Toshima S, Hasegawa A, Kurabayashi M, et al. Circulating oxidized low density lipoprotein levels: a biochemical risk marker for coronary heart disease. Arterioseler Thromb Vasc Biol, 2001,20: 2243-2247. 被引量：1
10Holvoet P, Mertens A, Verhamme P, et al. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol, 2001,21: 844-848. 被引量：1
8Nyhlorn B, Nielsen MF, Kristensen K, et al. Evidence of in creased visceral obesity and reduced physical fitness in healthy in sulin-resistant first-degree relatives of type 2 diabetic patients. Eur J Endocrinol,2004,150:207. 被引量：1
9Bays H, Mandarino L, Defromzo RA. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mel- litus : peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. Clin Endocrinol Metab, 2004, 89 : 463. 被引量：1
10Das A, Mcguire PG, Eriqat C, et al. Human diabetic neovascu- lar membrance contain high levels of urokinase and metallo-pro teinase enzymes. Invet Ophthalmol Vis Sci, 1999,40 : 809. 被引量：1
